Global Oncolytic Virus Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
According to APO Research, The global Oncolytic Virus Therapy market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oncolytic Virus Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
According to APO Research, The global Oncolytic Virus Therapy market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oncolytic Virus Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Oncolytic Virus Therapy Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Oncolytic Virus Therapy Market Size by Region (2019-2030)
1.4.1 Global Oncolytic Virus Therapy Market Size by Region (2019-2024)
1.4.2 Global Oncolytic Virus Therapy Market Size by Region (2025-2030)
1.5 Key Regions Oncolytic Virus Therapy Market Size (2019-2030)
1.5.1 North America Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.2 Europe Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.4 Latin America Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
2 ONCOLYTIC VIRUS THERAPY MARKET BY TYPE
2.1 Type Introduction
2.1.1 HSV-based Oncolytic Viruses
2.1.2 Adenoviruses-based Oncolytic Viruses
2.1.3 Vaccinia Virus-based Oncolytic Viruses
2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.1.5 Newcastle Disease Virus-based Oncolytic Viruses
2.2 Global Oncolytic Virus Therapy Market Size by Type
2.2.1 Global Oncolytic Virus Therapy Market Size Overview by Type (2019-2030)
2.2.2 Global Oncolytic Virus Therapy Historic Market Size Review by Type (2019-2024)
2.2.3 Global Oncolytic Virus Therapy Market Size Forecasted by Type (2025-2030)
2.3 Global Oncolytic Virus Therapy Market Size by Regions
2.3.1 North America Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
3 ONCOLYTIC VIRUS THERAPY MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Melanoma
3.1.2 Prostate Cancer
3.1.3 Breast Cancer
3.1.4 Ovarian Cancer
3.1.5 Others
3.2 Global Oncolytic Virus Therapy Market Size by Application
3.2.1 Global Oncolytic Virus Therapy Market Size Overview by Application (2019-2030)
3.2.2 Global Oncolytic Virus Therapy Historic Market Size Review by Application (2019-2024)
3.2.3 Global Oncolytic Virus Therapy Market Size Forecasted by Application (2025-2030)
3.3 Global Oncolytic Virus Therapy Market Size by Regions
3.3.1 North America Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Oncolytic Virus Therapy Industry Trends
4.2 Oncolytic Virus Therapy Industry Drivers
4.3 Oncolytic Virus Therapy Industry Opportunities and Challenges
4.4 Oncolytic Virus Therapy Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Oncolytic Virus Therapy Revenue (2019-2024)
5.2 Global Oncolytic Virus Therapy Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Oncolytic Virus Therapy Key Company Headquarters & Area Served
5.4 Global Oncolytic Virus Therapy Company, Product Type & Application
5.5 Global Oncolytic Virus Therapy Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Oncolytic Virus Therapy Market CR5 and HHI
5.6.2 Global Top 5 and 10 Oncolytic Virus Therapy Players Market Share by Revenue in 2023
5.6.3 2023 Oncolytic Virus Therapy Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Amgen
6.1.1 Amgen Comapny Information
6.1.2 Amgen Business Overview
6.1.3 Amgen Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Amgen Oncolytic Virus Therapy Product Portfolio
6.1.5 Amgen Recent Developments
6.2 Oncolytics Biotech
6.2.1 Oncolytics Biotech Comapny Information
6.2.2 Oncolytics Biotech Business Overview
6.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
6.2.5 Oncolytics Biotech Recent Developments
6.3 Viralytics
6.3.1 Viralytics Comapny Information
6.3.2 Viralytics Business Overview
6.3.3 Viralytics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Viralytics Oncolytic Virus Therapy Product Portfolio
6.3.5 Viralytics Recent Developments
6.4 Transgene SA
6.4.1 Transgene SA Comapny Information
6.4.2 Transgene SA Business Overview
6.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
6.4.5 Transgene SA Recent Developments
6.5 Oncolys BioPharma
6.5.1 Oncolys BioPharma Comapny Information
6.5.2 Oncolys BioPharma Business Overview
6.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
6.5.5 Oncolys BioPharma Recent Developments
6.6 Targovax
6.6.1 Targovax Comapny Information
6.6.2 Targovax Business Overview
6.6.3 Targovax Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Targovax Oncolytic Virus Therapy Product Portfolio
6.6.5 Targovax Recent Developments
6.7 PsiOxus Therapeutics
6.7.1 PsiOxus Therapeutics Comapny Information
6.7.2 PsiOxus Therapeutics Business Overview
6.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
6.7.5 PsiOxus Therapeutics Recent Developments
6.8 SillaJen Biotherapeutics
6.8.1 SillaJen Biotherapeutics Comapny Information
6.8.2 SillaJen Biotherapeutics Business Overview
6.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
6.8.5 SillaJen Biotherapeutics Recent Developments
6.9 Sorrento Therapeutics
6.9.1 Sorrento Therapeutics Comapny Information
6.9.2 Sorrento Therapeutics Business Overview
6.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
6.9.5 Sorrento Therapeutics Recent Developments
6.10 Lokon Pharma
6.10.1 Lokon Pharma Comapny Information
6.10.2 Lokon Pharma Business Overview
6.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
6.10.5 Lokon Pharma Recent Developments
6.11 Genelux Corporation
6.11.1 Genelux Corporation Comapny Information
6.11.2 Genelux Corporation Business Overview
6.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
6.11.5 Genelux Corporation Recent Developments
6.12 Vyriad
6.12.1 Vyriad Comapny Information
6.12.2 Vyriad Business Overview
6.12.3 Vyriad Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Vyriad Oncolytic Virus Therapy Product Portfolio
6.12.5 Vyriad Recent Developments
6.13 TILT Biotherapeutics
6.13.1 TILT Biotherapeutics Comapny Information
6.13.2 TILT Biotherapeutics Business Overview
6.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
6.13.5 TILT Biotherapeutics Recent Developments
6.14 Cold Genesys
6.14.1 Cold Genesys Comapny Information
6.14.2 Cold Genesys Business Overview
6.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
6.14.5 Cold Genesys Recent Developments
7 NORTH AMERICA
7.1 North America Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.3 North America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
8.3 Europe Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.3 Asia-Pacific Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.3 Latin America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
11.3 Middle East & Africa Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Oncolytic Virus Therapy Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Oncolytic Virus Therapy Market Size by Region (2019-2030)
1.4.1 Global Oncolytic Virus Therapy Market Size by Region (2019-2024)
1.4.2 Global Oncolytic Virus Therapy Market Size by Region (2025-2030)
1.5 Key Regions Oncolytic Virus Therapy Market Size (2019-2030)
1.5.1 North America Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.2 Europe Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.4 Latin America Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate (2019-2030)
2 ONCOLYTIC VIRUS THERAPY MARKET BY TYPE
2.1 Type Introduction
2.1.1 HSV-based Oncolytic Viruses
2.1.2 Adenoviruses-based Oncolytic Viruses
2.1.3 Vaccinia Virus-based Oncolytic Viruses
2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.1.5 Newcastle Disease Virus-based Oncolytic Viruses
2.2 Global Oncolytic Virus Therapy Market Size by Type
2.2.1 Global Oncolytic Virus Therapy Market Size Overview by Type (2019-2030)
2.2.2 Global Oncolytic Virus Therapy Historic Market Size Review by Type (2019-2024)
2.2.3 Global Oncolytic Virus Therapy Market Size Forecasted by Type (2025-2030)
2.3 Global Oncolytic Virus Therapy Market Size by Regions
2.3.1 North America Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Oncolytic Virus Therapy Market Size Breakdown by Type (2019-2024)
3 ONCOLYTIC VIRUS THERAPY MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Melanoma
3.1.2 Prostate Cancer
3.1.3 Breast Cancer
3.1.4 Ovarian Cancer
3.1.5 Others
3.2 Global Oncolytic Virus Therapy Market Size by Application
3.2.1 Global Oncolytic Virus Therapy Market Size Overview by Application (2019-2030)
3.2.2 Global Oncolytic Virus Therapy Historic Market Size Review by Application (2019-2024)
3.2.3 Global Oncolytic Virus Therapy Market Size Forecasted by Application (2025-2030)
3.3 Global Oncolytic Virus Therapy Market Size by Regions
3.3.1 North America Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Oncolytic Virus Therapy Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Oncolytic Virus Therapy Industry Trends
4.2 Oncolytic Virus Therapy Industry Drivers
4.3 Oncolytic Virus Therapy Industry Opportunities and Challenges
4.4 Oncolytic Virus Therapy Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Oncolytic Virus Therapy Revenue (2019-2024)
5.2 Global Oncolytic Virus Therapy Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Oncolytic Virus Therapy Key Company Headquarters & Area Served
5.4 Global Oncolytic Virus Therapy Company, Product Type & Application
5.5 Global Oncolytic Virus Therapy Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Oncolytic Virus Therapy Market CR5 and HHI
5.6.2 Global Top 5 and 10 Oncolytic Virus Therapy Players Market Share by Revenue in 2023
5.6.3 2023 Oncolytic Virus Therapy Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Amgen
6.1.1 Amgen Comapny Information
6.1.2 Amgen Business Overview
6.1.3 Amgen Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Amgen Oncolytic Virus Therapy Product Portfolio
6.1.5 Amgen Recent Developments
6.2 Oncolytics Biotech
6.2.1 Oncolytics Biotech Comapny Information
6.2.2 Oncolytics Biotech Business Overview
6.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
6.2.5 Oncolytics Biotech Recent Developments
6.3 Viralytics
6.3.1 Viralytics Comapny Information
6.3.2 Viralytics Business Overview
6.3.3 Viralytics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Viralytics Oncolytic Virus Therapy Product Portfolio
6.3.5 Viralytics Recent Developments
6.4 Transgene SA
6.4.1 Transgene SA Comapny Information
6.4.2 Transgene SA Business Overview
6.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
6.4.5 Transgene SA Recent Developments
6.5 Oncolys BioPharma
6.5.1 Oncolys BioPharma Comapny Information
6.5.2 Oncolys BioPharma Business Overview
6.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
6.5.5 Oncolys BioPharma Recent Developments
6.6 Targovax
6.6.1 Targovax Comapny Information
6.6.2 Targovax Business Overview
6.6.3 Targovax Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Targovax Oncolytic Virus Therapy Product Portfolio
6.6.5 Targovax Recent Developments
6.7 PsiOxus Therapeutics
6.7.1 PsiOxus Therapeutics Comapny Information
6.7.2 PsiOxus Therapeutics Business Overview
6.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
6.7.5 PsiOxus Therapeutics Recent Developments
6.8 SillaJen Biotherapeutics
6.8.1 SillaJen Biotherapeutics Comapny Information
6.8.2 SillaJen Biotherapeutics Business Overview
6.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
6.8.5 SillaJen Biotherapeutics Recent Developments
6.9 Sorrento Therapeutics
6.9.1 Sorrento Therapeutics Comapny Information
6.9.2 Sorrento Therapeutics Business Overview
6.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
6.9.5 Sorrento Therapeutics Recent Developments
6.10 Lokon Pharma
6.10.1 Lokon Pharma Comapny Information
6.10.2 Lokon Pharma Business Overview
6.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
6.10.5 Lokon Pharma Recent Developments
6.11 Genelux Corporation
6.11.1 Genelux Corporation Comapny Information
6.11.2 Genelux Corporation Business Overview
6.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
6.11.5 Genelux Corporation Recent Developments
6.12 Vyriad
6.12.1 Vyriad Comapny Information
6.12.2 Vyriad Business Overview
6.12.3 Vyriad Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Vyriad Oncolytic Virus Therapy Product Portfolio
6.12.5 Vyriad Recent Developments
6.13 TILT Biotherapeutics
6.13.1 TILT Biotherapeutics Comapny Information
6.13.2 TILT Biotherapeutics Business Overview
6.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
6.13.5 TILT Biotherapeutics Recent Developments
6.14 Cold Genesys
6.14.1 Cold Genesys Comapny Information
6.14.2 Cold Genesys Business Overview
6.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
6.14.5 Cold Genesys Recent Developments
7 NORTH AMERICA
7.1 North America Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.3 North America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
8.3 Europe Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.3 Asia-Pacific Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.3 Latin America Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
11.3 Middle East & Africa Oncolytic Virus Therapy Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
